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ARTICLE
Flexible-to-rigid transition is central for substrate
transport in the ABC transporter BmrA from
Bacillus subtilis
Denis Lacabanne 1,3, Cédric Orelle1,3, Lauriane Lecoq1, Britta Kunert1, Claire Chuilon1, Thomas Wiegand2,
Stéphanie Ravaud1, Jean-Michel Jault1, Beat H. Meier 2 & Anja Böckmann 1
ATP-binding-cassette (ABC) transporters are molecular pumps that translocate molecules
across the cell membrane by switching between inward-facing and outward-facing states.
To obtain a detailed understanding of their mechanism remains a challenge to structural
biology, as these proteins are notoriously difﬁcult to study at the molecular level in their
active, membrane-inserted form. Here we use solid-state NMR to investigate the multidrug
ABC transporter BmrA reconstituted in lipids. We identify the chemical-shift differences
between the inward-facing, and outward-facing state induced by ATP:Mg2+:Vi addition.
Analysis of an X-loop mutant, for which we show that ATPase and transport activities are
uncoupled, reveals an incomplete transition to the outward-facing state upon ATP:Mg2+:Vi
addition, notably lacking the decrease in dynamics of a deﬁned set of residues observed in
wild-type BmrA. This suggests that this stiffening is required for an efﬁcient transmission of
the conformational changes to allow proper transport of substrate by the pump.
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ATP-binding cassette (ABC) exporters can translocate avariety of molecules across the cell membrane via an ATPfueled engine. Notably exporters can be involved in
multidrug resistance phenotypes, thereby participating to anti-
microbial resistance in yeasts and bacteria, or drug resistance
in human anti-cancer chemotherapies. Energy for transport in
these proteins is provided through a catalytic cycle, occurring
in the nucleotide-binding domains (NBDs), including ATP
binding, hydrolysis, and ADP/inorganic phosphate (Pi) release.
ABC transporters generally function via an alternating access
mechanism in which the catalytic cycle in the NBDs is coupled
to the re-orientation of the transmembrane domains (TMDs).
The conformational changes, transmitted from the NBDs to the
TMDs, reorient the drug-binding site from an inward-facing (IF)
to an outward-facing (OF) conformation, resulting in the trans-
location of drugs across the membrane1–4 (see Fig. 1a for a
schematic representation).
In exporters, the mode of transmission of the conformational
changes between the NBDs and the TMDs remains unclear,
although it presumably involves regions of the NBDs that contact
the coupling helices of the TMDs2,5–7. The transition from the
inward-facing to the outward-facing state represents a key event
in the pump catalytic cycle and it may coincide with substrate
export, although this point is debated for one transporter8. It has
been described to be either coupled to ATP binding9,10 or ATP
hydrolysis8,11,12. Two main models have been proposed: the
ATP-switch model13 (or the related processive clamp model14)
in which ATP binding brings the two NBDs into contact and the
constant contact model15, where the NBDs remain in contact
and ATP is hydrolyzed alternatively in one or the other16. Today,
no experimental technique is available which allows following
in real time the conformational states induced by drug binding
and ATP-hydrolysis events. Still, a tool-box of ATP analogs and
mutant constructs has been devised to allow approximate instant
snapshots, which capture trapped states, designed to be as close
to the actual states of the transport cycle as possible9. In this
context, studying the protein in membranes is a clear asset as
it allows to better mimic functional states17.
We here use the homodimeric multidrug ABC exporter BmrA
from B. subtilis (130 kDa), which has been identiﬁed in the
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Fig. 1 ABC transporter export cycle and samples studied. a Putative export cycle of an ABC exporter adapted from Grossmann et al.26 and Parcej et al.27. A
sketched model of the BmrA homodimer is given in gray, ATP is indicated in red, and ADP in yellow. Bound nucleotides in undetermined hydrolysis states
are shown in gray. bMimics of different BmrA states investigated, as desribed in the text. c BmrA homology model based on Sav1866 (pdb 2hyd2), the two
mononers are shown in light gray and dark gray colors. Mutated residues are highligthed, with E474 from the X-loop motif (470-TEVGERG-476) in green,
residue K380 from the Walker A motif (374-GPSGGKT-381) in magenta, and residue E504 from Walker B (496-ILMLDE-504) in dark yellow. The ABC
signature (477-LSGGQ-483, in blue) and the H-loop (532-AHR-536, in cyan) motifs are also presented. d View of the NBDs of BmrA modeled on Sav1866
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B. subtilis genome by homology with the human P-
glycoprotein18. BmrA is able to transport multiple substrates,
including Hoechst 33342 and doxorubicin19, and the antibiotic
cervimycin C20. While high-resolution 3D structures of BmrA
remain to be determined, different conformational states have
been characterized for the apo and ADP:Mg:Vi-trapped forms
using biochemical studies21,22, electron microscopy23, and EPR
spectroscopy24. We here investigate, using solid-state NMR, dif-
ferent conformational states of BmrA reconstituted in B. subtilis
lipids. NMR chemical shifts and intensities provide a speciﬁc
identity or ﬁngerprint for a given protein state, and changes
therein are highly sensitive probes for conformational and
dynamic changes. The states investigated are shown in Fig. 1b.
(Please note that we use hereafter Mg and Mn as short forms for
Mg2+, the natural cofactor that binds in the NBD, and Mn2+,
a paramagnetic replacement which typically preserves the func-
tionality of the transporter24.) We ﬁrst identiﬁed the NMR ﬁn-
gerprints of the wt:apo (IF) state in red, to use them together with
the spectra previously recorded on the wt:ADP:Mg:Vi (OF)
(in cyan) and wt:ADP:Mn:Vi (OF) (in purple) states24 as refer-
ence and basis to identify peaks close to the nucleotide-binding
site, or remote from it, via paramagnetic relaxation enhancements
(PREs). Wt:ADP:Mg:Vi (OF) mimics the ATP-hydrolysis tran-
sition state, and wt:ADP:Mn:Vi (OF) is its equivalent para-
magnetic state. We then compared them with two mutant
proteins: the non-hydrolytic mutant E504A and the X-loop
mutant E474R, with the position of the mutations highlighted
on the BmrA homology model shown in Fig. 1c. We analyzed
the conformational and dynamic features of the ATP-trapped
prehydrolytic state E504A:ATP:Mg (OF)25 (in blue, and E504A:
apo for reference in pink), and of the E474R:ADP:Mg:Vi X-loop
mutant, where the conserved residue E474 is replaced by an
arginine (in orange), and E474R:apo (in green).
These NMR analyses allowed us to show that ATP binding is
sufﬁcient for BmrA in membranes for transition to the outward-
facing state, and no hydrolysis is needed at this stage. We
established that the X-loop mutant E474R showed uncoupled
transport and ATPase activities, and determined that stiffening
of a subset of residues seems central in connecting these two
processes in order to transform the chemical energy from ATP
hydrolysis into mechanical energy to achieve transport.
Results
All spectra shown in the following have been recorded on
selectively unlabeled [12C-14N-LVIKHP]-13C-15N protein28 in
order to decongest the spectra. Figure 2 shows extracts of the A-
la region of the 2D 13C–13C DARR correlation spectra.
Full spectra were analyzed and are shown in the Supplementary
Figures indicated. Coloring of the spectra is according to icons
in Fig. 1b. Individual serial numbers are assigned to all peaks
which were analyzed, in addition to individual assignments
where available24. More complete sequential assignments remain
largely out of reach for this 589-residue protein today (as dis-
cussed in detail in Supplementary Fig. 1 caption).
The transporter stiffens upon transition to the outward-facing
state. In the apo state, BmrA in lipids adopts an inward-facing
conformation23, which, under the conditions used, forms meso-
scopic ring-shaped particles that assemble further into tubes29–31.
We have recorded spectra of this wt:apo (IF) state, and compared
them with spectra previously recorded on the protein in presence
of vanadate, ATP, and magnesium24, which traps the transporter
in an outward-facing conformation mimicking the transition
state. We veriﬁed that the wt:ADP:Mg:Vi form was trapped in the
outward-facing state, by addition of ATP:Mg:Vi and limited
proteolysis using trypsin (Supplementary Fig. 2). Indeed, only the
outward-facing state resists to trypsin digestion22.
Extracts of the alanine region of the spectra of the two samples
are shown in Fig. 2 in red for the wt:apo (IF) state, and in cyan for
the wt:ADP:Mg:Vi (OF) state (for larger extracts see Supplemen-
tary Fig. 3A). The overlay reveals several peaks shifting to
different resonance frequencies, which we refer to as chemical-
shift perturbations (CSPs)32, and which vary here between
0.15 ppm, a threshold which corresponds to more than half of
the NMR signal linewidth, and 1 ppm (Supplementary Fig. 3B).
CSPs alone can, however, not account for all differences in the
spectra, since one can notice, also in Supplementary Fig. 3, that
the spectra of the wt:ADP:Mg:Vi (OF) state feature a large
number of additional cross peaks, localized by red circles in the
spectrum of the wt:apo (IF) state in Fig. 2a. In solid-state NMR
measurements, residues showing dynamics with sizeable ampli-
tude on a microsecond time scale are strongly broadened, which
can attenuate their peak amplitude beyond detection. The
broadening is due to interference of the protein dynamics with
the heteronuclear decoupling and/or magic-angle spinning. Thus,
additional signals appearing in protein spectra indicate a decrease
in the ﬂexibility of the corresponding residues (if they are not
observed in solution-type INEPT spectra, which is not the case
here). Further characterization of the dynamics is difﬁcult, as
the peaks are not even observed at the lowest temperatures
where resolution is, at least partially, retained (here −10 °C). At
even lower temperatures, resolution deteriorates severely, as
generally observed in solid-state NMR of proteins33. Four of the
six Ala resonances not observed in the wt:apo (IF) state are clearly
located in regions indicative for β-sheets or turns, remote from
the region around 55 and 18 ppm, where the large signals from
α-helical Ala residues concentrate, and three of them could
indeed be assigned to residues in β-sheets (A371, A505, A534)24
(Supplementary Fig. 1). These alanines belong to the NBD of
BmrA and they are highlighted in a homology model built from
Sav1866 in Fig. 1d. Two more peaks are located in turn regions
(#38, 41). While the additional resonances in wt:ADP:Mn:Vi
(OF) could in principle originate also from peak doubling due
to occupation of only a single ATP:Mg-binding site, we can
exclude this due to the large excess of ATP:Mg (×3000) added to
induce the outward-facing. Moreover, EPR distance measure-
ments on the Mn2+-substituted protein revealed a distance of
1.9 nm between the two Mn2+ atoms, as expected from the
homology model of the outward-facing state. This shows that
both sites were indeed occupied by nucleotides-Mn in wt:ADP:
Mn:Vi (OF)24. Eight other signals only visible in the spectra of
the wt:ADP:Mn:Vi (OF) state can be identiﬁed in the remaining
regions of the spectrum (peaks in Supplementary Fig. 3A, gray
bars in Supplementary Fig. 3B).
The rigid residues in the outward-facing state are located in the
NBDs. Three Ala residues which are only observed in wt:ADP:
Mg:Vi (OF) state could be assigned to individual amino acids and
are located within the NBD, namely A371, A505, and A534. In
order to see whether this localization can be generalized to the
other eleven residues only observed in wt:ADP:Mg:Vi (OF), we
used paramagnetic relaxation enhancements to assign the signals
to two different regions of the protein, near the ATP-binding
site (mainly NBD), and remote from it, including, but not fully
restricted to, the TMD. Indeed, Mn2+ induces PREs that strongly
attenuate resonances from 13C spins located within a radius of
about 15 Å around the metal ion in 2D DARR spectra24, which
concerns exclusively resonances in the NBD, as shown on a BmrA
homology model from Sav18662 in Supplementary Fig. 4C. The
resonances which are far from the Mn2+ binding site, notably
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from the TMD, will not be attenuated by PREs and remain visible
in the spectrum. It should be noted that when the Mg2+ is
replaced by Mn2+, the protein retains full transport activity24.
We thus compared the spectra of wt:ADP:Mg:Vi (OF) and wt:
ADP:Mn:Vi (OF)24 with those of the wt:apo (IF) state to identify
which of the analyzed residues are in the vicinity of the Mn2+
metal ion. In the left panel of Fig. 2b, the spectra of wt:ADP:Mg:
Vi (OF) and wt:ADP:Mn:Vi (OF) states are superimposed (larger
extracts are shown in Supplementary Fig. 4A). Signals clearly
observed only in wt:ADP:Mg:Vi (OF) are highlighted, in the
middle panel, by purple circles. Interestingly, when overlaying
spectra recorded on wt:ADP:Mn:Vi with those recorded on the
wt:apo (IF) state (right panel), one can see that ﬁve out of six Ala
residues are invisible in both spectra when compared with wt:
ADP:Mg:Vi (OF) (dashed red/purple circles). The other alanine
(#40) is strongly attenuated in the wt:ADP:Mn:Vi (OF) spectrum.
A similar conclusion holds for the remaining analyzed signals
(Supplementary Fig. 4B), where only two (#40 and 45) show weak
signals, and the others are not observed. The Cα atoms of the
three assigned Ala residues (A371, A505, A534) are indeed
located, in the BmrA homology model, at 12.6, 9.9, and 8.0 Å
from the metal center, close to the Walker A motif (375-
GPSGGKT-381) which wraps around the β- and γ-phosphate of
ATP, the catalytic glutamate E504 located in the Walker B motif,
and the H-loop motif which forms a chemical hinge between the
catalytic glutamate and the γ-phosphate of ATP (Fig. 1c).
Because of the similarity between the wt:ADP:Mn:Vi (OF) and
the wt:apo (IF) spectra, one could argue that the protein did
not bind the paramagnetic ion, and remained in wt:apo (IF).
The observation by EPR of two Mn2+ ions per dimer in this
preparation provides, however, evidence that the ions are bound,
and that the protein is indeed in wt:ADP:Mn:Vi (OF)24. Further
evidence for successful binding stems from a comparison of
spectral ﬁngerprints presented in Supplementary Fig. 5, which
show that NMR signals which are not attenuated in the wt:ADP:
Mn:Vi (OF) spectrum indeed do show the typical chemical-shift
ﬁngerprint observed for wt:ADP:Mg:Vi (OF) and not the one
corresponding to wt:apo (IF). We can thus conclude that the
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residues that show dynamic behavior in wt:apo (IF) and become
rigid in wt:ADP:Mg:Vi (OF), i.e., the residues which are stiffening
when the transporter is in the trapped transition state as opposed
to the apo state, are located in the NBDs.
ATP hydrolysis is not required to induce the outward-facing
state. With the catalytic mutation E504A adjacent to the Walker-
B motif, BmrA binds, but does not hydrolyze ATP25. The mutant
has been shown to still undergo, in analogy to wild-type BmrA, a
conformational change on incubation with ATP:Mg, destroying
the typical mesoscopic ring structures BmrA can form in the wt:
apo (IF) state21. While wt:ADP:Mg:Vi (OF) can be considered as
an ATP hydrolysis transition-state mimic, E504A:ATP:Mg (OF)
mimics a prehydrolytic ATP-trapped state25. The comparison
between the spectra of wt:apo and E504A:apo both in inward-
facing state (Supplementary Fig. 6A) reveals largely similar
spectra. The two proteins in the presence of nucleotides also look
highly similar, as shown in Fig. 2c (for larger extract see Sup-
plementary Fig. 6B, and for numerical analysis Supplementary
Fig. 6C), where the few differences, likely due to the mutation, are
indicated by circles. E504A:ATP:Mg (OF) thus clearly shows the
ﬁngerprint of wt:ADP:Mg:Vi (OF), which allows us to conclude
that no ATP hydrolysis is needed to induce the outward-facing
state of BmrA in lipids, and that for the mimics used here,
the conformation of the outward-facing transition state is, on a
molecular level, highly similar to the outward-facing pre-
hydrolytic state in BmrA. This is consistent with the results
of Oldham and Chen on the maltose transporter, who showed
that, there as well, these two states are essentially similar and
could be discernable only in few residues at the level of side-chain
in the catalytic site34–36.
BmrA E474R uncouples ATPase and transport activities. In
ABC exporters, the X-loop has been proposed to play a pivotal
role as a connecting part between the NBD and the TMD2,7,37,38.
It contains a strictly conserved glutamate residue (sequence
LPNQFDTEVGE474RGIML in BmrA). We prepared the X-loop
mutants E474D, E474Q, E474F, E474A, and E474R (see Fig. 1c)
and studied their doxorubicin and Hoechst 33342 transport
activities using inverted E. coli membrane vesicles containing
the overexpressed proteins19. All mutants were expressed and
incorporated at similar levels in the membrane fractions (Sup-
plementary Fig. 7). We ﬁrst compared the transport activity of
each mutant with the wild-type, and also the Walker-A (K380A)
and catalytic glutamate (E504A) inactive mutants21. The doxor-
ubicin transport proﬁles as measured by real-time ﬂuorescence
spectroscopy are displayed in Fig. 3a (for Hoechst 33342 see
Supplementary Fig. 8), and the deduced initial rates are shown in
Fig. 3b. It can be clearly seen that the E474R mutant features no
transport activity, as also the controls (K380A and E504A).
Mutants E474D, E474Q, E474F, and E474A display about 75, 60,
35, and 25%, respectively, of the wild-type protein transport
activity. This highlights the deleterious effect of X-loop mutations
on transport activity, as also reported for Tap1/Tap27. In order
to avoid the high background of ATPase activity due to the
presence of numerous ATPases in inverted membrane vesicles,
we puriﬁed each protein and studied the ATPase activity after
reconstitution into proteoliposomes (Fig. 3c). Importantly, the
difference between wild-type and mutant proteins is rather small,
with the E474R mutant still showing ∼70% activity of the wild-
type BmrA ATPase activity. The control (K380A) shows no
ATPase activity at all, as observed before21. This allowed us to
conclude that the mutation hardly impacts the motor domain,
which remains almost fully functional in E474R BmrA.
In order to verify that impaired transport is not due to altered
drug-binding afﬁnity in the mutant, we monitored binding of
doxorubicin and Hoechst 33342 to wild-type and E474R BmrA
using intrinsic ﬂuorescence quenching. KD values (with standard
deviations) of 17 ± 10 μM and 14 ± 8 μM were obtained for
doxorubicin binding to wild-type and mutant proteins, respec-
tively, and 12 ± 3 μM and 10 ± 5 μM for Hoechst 33342,
conﬁrming that both proteins bind these compounds with similar
afﬁnity. It has been shown that the ATPase activity of BmrA is
slightly stimulated by the presence of drugs, e.g., reserpine19. We
measured drug-stimulated ATPase activities of both wild-type
BmrA and the E474R mutant, which are both increased by
15% in presence of 3.5 μM reserpine (Supplementary Fig. 9). The
observation that the E474R mutant is able to hydrolyze ATP
and to bind drugs, but fails to transport them, points to an
impaired transmission between the engine (NBDs) and the TMDs
in this mutant.
BmrA E474R makes an incomplete switch to the outward-
facing state. In order to investigate the structural basis of the
impaired transport activity of the E474R mutant, we recorded
spectra of E474R:apo (IF) and E474R:ADP:Mg:Vi (we veriﬁed
that the ATPase activity of E474R is indeed sensitive to Vi, with
an IC50 of 50 µM vs 10 µM for the wt; Supplementary Fig. 10).
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A comparison of E474R:apo (IF) with wt:apo (IF) (Supplemen-
tary Fig. 11) shows that both spectra are highly similar.
More interesting is the comparison of the E474R:ADP:Mg:Vi
to wt:ADP:Mg:Vi (OF) and wt:apo (IF), as shown in Fig. 4a–d for
the Ala region (and in Supplementary Fig. 12 for larger spectral
extracts). One can see that several residues observed in the spectra
of wt:ADP:Mg:Vi (OF) (Fig. 4a) are actually not observed in
the E474R:ADP:Mg:Vi (orange circles in Fig. 4b). Interestingly,
these signals coincide largely with those not observed in the wt:
apo (IF), as can be seen in the overlay in Fig. 4d, highlighted
by the coinciding red/orange circles. For peak #37 (A505), which
corresponds to the neighboring residue to the catalytic glutamate
(E504), the signal is still observable, but strongly attenuated
(factor of 0.4). With respect to dynamics, a similar state to wt:apo
(IF) is thus observed for E474R:ADP:Mg:Vi, also indicated by
the gray bars in Fig. 4e.
The situation is different with respect to chemical shifts and
thus conformation. Figure 4e displays the differences, for peaks
1–33, between the wt:apo (IF)/E474R:ADP:Mg:Vi and the wt:
ADP:Mg:Vi (OF)/E474R:ADP:Mg:Vi CSPs as a measure for the
similarity of the mutant conformation to either inward-facing
or outward-facing states. Negative cyan bars indicate that the
peak is closer to wt:ADP:Mg:Vi (OF), and positive red bars that
the peak is closer to wt:apo (IF). Twenty-ﬁve out of 33 analyzed
peaks show negative values, indicative for higher similarity with
wt:ADP:Mg:Vi (OF). Interestingly, the chemical shifts of all these
peaks point to β-strand secondary structures39, exclusively found
in the NBDs. This means that at least the β-sheet parts of the
NBDs are largely in a conformation similar to wt:ADP:Mg:Vi
(OF). Out of the eight peaks with positive values, closer to wt:apo
(IF), seven are found in spectral regions rather corresponding
to α-helical secondary structure, as indicated by the α above the
bars. Out of these seven peaks, only one (#12) is fully attenuated
by the presence of Mn (Supplementary Fig. 4B). The others are
thus located remotely from the Mn binding site, toward the
interface with, or inside the TMDs. The analysis thus points,
with respect to conformation, to a mixed state, with the majority
of β-strand residues close to wt:ADP:Mg:Vi (OF), and α-helical
residues, mainly distant to the active site, close to wt:apo (IF).
This strongly suggests that the state induced in the E474R
mutant by the presence of ADP:Mg:Vi can be characterized as
an incomplete outward-facing state, in which the NBDs are
engaged, thereby trapping the ADP:Mg:Vi at their interface,
while remote regions, including the TMDs remain essentially in
an inward-facing conformation or an occluded state as observed
with McjD40. These results point, together with the persistent
dynamics (i.e., absence of stiffening), to a rationale for the lack
of export activity observed in the mutant.
Discussion
In this work, we have analyzed key states in the transport cycle of
an ABC multidrug exporter. We have shown, using the E504A
mutant of BmrA, that the inward-facing state (Fig. 5a) can switch
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to the outward-facing state without ATP hydrolysis, as recapi-
tulated in the cartoon in Fig. 5b. If substrate release is linked in
BmrA to the outward-facing transition (which remains to be
demonstrated), this would mean that drug release takes place
without hydrolysis, as recently proposed for MRP141 and P-
glycoprotein transporters42. We could show, at atomic level and
for the membrane-inserted protein, that the conformation of the
prehydrolytic state of BmrA is very similar to that of the transi-
tion state (Fig. 5c), as their spectra are, within the technical limits
(i.e., linewidth, spectral overlap, signal-to-noise ratio), virtually
the same.
It has been discussed in the literature whether in ABC trans-
porters, ATP binding occurs in a symmetric way with both sites
occupied15,43. In BmrA, we can identify symmetry, through the
absence of 13C peak doubling, which would support the ATP-
switch model13,44 involving symmetric nucleotide binding.
Importantly, not only conformational differences, but also
differences in dynamics occur between the inward-facing and
outward-facing states of BmrA, indicated by the concomitant
stiffening of a set of residues in the NBDs. Dynamic behavior in
ABC exporters has been identiﬁed by different techniques, such
as EPR on MsbA45,46, P-gp47, LmrA48, BmrCD11, and TM287/
2889, cryo-electron microscopy for CFTR49, ABCG250, MRP141,
P-glycroprotein transporters42, MsbA51, and solid-state NMR for
LmrA52 or even BmrA by H/D exchange coupled to mass spec-
trometry22. The dynamics we observe here for a set of residues is
not necessarily related with these observations from other tech-
niques. In EPR studies, ﬂexibility of the NBDs is revealed through
the presence of a variety, coexisting states, which are typically
frozen out, and whose presence leads to the detection of an
average distance distributions of varying amplitude between
NBDs. In cryo-electron microscopy, ﬂexibility in certain trans-
porters is revealed by entire loops or other parts of the protein
showing density which is too diffuse to be modeled accurately. In
contrast, our observations here by solid-state NMR, like those
reported in a parallel study on the DnaB helicase53, point to single
residues which, depending on the state of the protein, stiffen or
become ﬂexible on the time scale of the micro- to milliseconds.
These dynamics localize to a restricted set of residues, but clearly
do not concern the entire NBD (as indeed there are signals
present in the wt:apo state, which disappearance on addition of
Mn identiﬁes them as located in the NBDs). The peaks that show
up only in the wild-type (or E504A) protein nucleotide-bound
states thus represent a subset of amino acids only. These residues
become rigid when binding of ATP:Mg:Vi induces re-orienta-
tion of the drug-binding site to the outward-facing state, but
do not do so in the E474R mutant protein, where no transport
activity is observed. The X-loop has been described as a mediating
element connecting the conformational changes caused by ATP
hydrolysis in the NBDs to those in the TMDs. In the E474R
mutant, the observation of a closed NBD dimer but absence of
transport could thus be explained by a loss of coupling through
the “coupling helices”. This loss of coupling was also suggested
for the conserved Gln of the ABC signature in MDR3/ABCB437.
The stiffening of the dynamic residues on ADP:Mg:Vi binding to
the wild-type protein, not observed in the E474R mutant, may
indicate that a larger set of residues, including from the NBD
β-strands, play a role in this transmission. Thus, the loss of
dynamics may be required to transmit conformational change
from the NBDs to the cytoplasmic ends of the TMDs. This does
not only involve the coupling helices, but more likely a larger
network of atoms, resulting eventually in opening the drug-
binding pocket toward the outside thereby achieving transport.
ATP is hydrolyzed by the E474R mutant protein, which means
that the engine providing energy is intact. Still, this energy cannot
be transformed into mechanical energy where required (Fig. 5d).
To obtain a residue-speciﬁc view on which ones take part in this
dynamic change, more complete sequential resonance assign-
ments of the protein resonances will be needed. This might get
into reach with new NMR developments, as proton-detection
techniques, as well as the advent of higher magnetic ﬁelds deli-
vering the critical sensitivity and resolution for the site-speciﬁc
study of such large proteins as the one studied here.
Methods
NMR sample preparation. The production, puriﬁcation and reconstitution of
BmrA was done as described previously30,31. Selectively labeled BmrA was pro-
duced in M9-medium supplemented with natural abundance amino acids (see
below) in presence of 13C-glucose (2 g L−1) and 15N-ammonium chloride (2 g L−1)
as sole sources of carbon-13 and nitrogen-15. Pre-cultures, (i) 50 mL at 37 °C then
(ii) 150 mL at 25 °C inoculated with (i), were realized before the main culture. Eight
hundred and ﬁfty milliliters of M9-medium containing natural abundant Leu
(0.23 g L−1), Val (0.23 g L−1), Ile (0.23 g L−1), Lys (0.40 g L−1), His (0.40 g L−1),
and Pro (0.10 g L−1) was inoculated with the 150-mL pre-culture at 25 °C.
Induction was performed with 0.7 mM IPTG, OD600nm between 0.6 and 0.7. The
cells were harvested by centrifugation (6000 × g, 15 min) when the stationary phase
was reached. The cells were lysed by high pressure using a Microﬂuidics Micro-
ﬂuidizer® in a lysis buffer composed of 50 mM Tris-HCl pH 8.0, 5 mM MgCl2,
1 mM DTT, benzonase, and EDTA-free protease inhibitor cocktail. The solution
was centrifuged at 15,000 × g during 45 min, the pellet was discarded and the
supernatant was centrifuged at 200,000 × g during 1 h. The sedimented membranes
were suspended and collected in 50 mM Tris-HCl pH 8.0, 1 mM EDTA, and
300 mM sucrose. The protein-containing membranes were diluted at 2 mgmL−1,
22
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Fig. 5 Summary of our ﬁndings (highlighted in red). a BmrA in its inward-
facing state with a subset of residues showing dynamics on the
microsecond time scale, which are mainly located within 15 Å of the ATP:
Mg-binding site. b, c BmrA in its outward-facing state, in which a set of
residues stiffens, and conformational changes occur around the ATP-
binding site, but also remotely in an allosteric manner to allow drug
transport. d In the presence of ATP:Mg:Vi, the E474R mutant makes an
incomplete conformational and dynamic transition, with the NBDs engaged
in and ADP:Mg:Vi bound state, but with residues remaining ﬂexible, and
only partially observed CSPs
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solubilized using 1% DDM (m/v) and centrifuged at 100,000 × g for 1 h. The
supernatant was loaded onto a Ni-NTA column (Qiagen) equilibrated with 50 mM
Tris-HCl pH 8.0, 100 mM NaCl, 15% glycerol, 10 mM imidazole, and 0.2% DDM
(m/v). The Ni-NTA column was washed using equilibration buffer containing
0.5 M NaCl, then successively 30 mM imidazole, 40 mM imidazole, and 250 mM
imidazole for elution. The eluted protein was desalted using PD10 columns
(PD10 - GE Healthcare Life Sciences) which were equilibrated with 50 mM
Tris-HCl pH 8.0, 100 mM NaCl, 10% glycerol, and 0.2% DDM (m/v). In order to
decrease the concentration of DMM from 0.2 to 0.05% (m/v), the protein solution
was diluted four times with 50 mM Tris-HCl pH 8.0, 100 mM NaCl, and 5%
glycerol. The solution was mixed with a homemade preparation of B. subtilis
lipids30,31 solubilized in Triton X-100 with a molar ratio of 10:1 and incubated for
1 h. B. subtilis lipids in natural abundance are extracted from B. subtilis cultures
and mainly consist in cardiolipin, phosphatidylethanol-amine, phosphatidyl-gly-
cerol, and lysylphosphatidyl-glycerol (12:30:36:22)43. The quantity of lipid mix was
adjusted at a lipid-to-protein ratio (LPR, in m:m) of 0.5 or 20. The DDM and
Triton X-100 were removed using dialysis with Bio-beads (BioRad). The protein
solution was dialyzed against 50 mM Tris-HCl pH 8.0, 100 mM NaCl, and 5%
glycerol. during 9 days31. An excess of Bio-beads was used. This excess correspond
to three times the theoretical amount required to absorb the DDM (1 g Bio-beads
for 105 mg) and Triton X-100 (1 g Bio-beads for 70 mg).
For the preparation of the BmrA:ADP:Mg:Vi or BmrA:ADP:Mn:Vi complexes,
the protein solutions, after 9 days of dialysis, were incubated with 1 mM Na3VO4,
then 10 mM ATP and 10 mM Mg2+ or 1 mM Mn2+ during 1 h. For the BmrA-
E504A:ATP:Mg complex, the solution was incubated with 10 mM ATP and 10 mM
Mg2+ during 1 h. The protein in lipids was sedimented into the MAS-NMR rotor
(1 h at 4 °C with 120,000 × g) using home-build tools54. For each sample, 4 L of
carbon-13, nitrogen-15 culture yielding a total of 40 mg protein were produced.
Preparation of BmrA mutants. Site-directed mutagenesis of BmrA X-loop
mutants was performed using a Quikchange lightning kit provided by Agilent.
The design of the primers was done following the instruction of the provider.
K380A and E504A mutants were previously prepared21,25. All mutants gave similar
expression and puriﬁcation levels. Hundred-percent ATPase activity in Fig. 3c
corresponded to ~ 6 μmol min−1 mg−1.
Solid-state NMR experiments. NMR spectra of all samples were acquired on a
Bruker Avance spectrometer operating at 800MHz 1H frequency using a 3.2 mm
triple-resonance E-free probe. The sample temperature was set to 278 K using
the water resonance frequency as a reference31. The 2D spectra were processed
using TOPSPIN 3.555 with a shifted cos2 function with SSB=3 and analyzed using
CcpNMR software56. No custom codes were used. The details of NMR experiments
are given in the Supplementary Table 1.
Drug transport activity of BmrA in presence of Mg2+. Drug transport was
followed using ﬂuorescence spectroscopy19. In a 1 mL cuvette, 100 µg of inverted
membrane vesicles from E. coli C41(DE3) overexpressing BmrA were incubated
in presence of 2 mM ATP, 4 mM phosphoenolpyruvate, and 60 µg mL−1 pyruvate
kinase. After 1 min incubation at 25 °C, 10 µM doxorubicin were added and the
transport reaction was initiated by adding 2 mM MgCl2. The excitation and
emission wavelengths used were 480 and 590 nm, respectively. Fluorescence
measurements were carried out using a Photon Technology International spectro-
ﬂuorimeter with an 814 photomultiplier detection system using a 75W xenon
short arc lamp.
ATPase activity assay in micro-plate. ATPase activity was monitored using
an ATP/NADH coupled assay in micro-plates31. In total, 0.1 µg of reconstituted
BmrA (LPR 20) was mixed in 50 mM HEPES-KOH pH 8, 4 mM phosphoe-
nolpyruvate, 60 µg mL−1 pyruvate kinase, 32 µg mL−1 lactate dehydrogenase,
10 mM MgCl2, and 0.6 mM NADH. The reaction was started by the addition of
5 mM ATP and the decreasing absorbance of NADH was followed at 340 nm
during the reaction (spectrophotometer SAFAS FLX-Xenius®) during 20 min.
Fluorescence binding experiments. Hoechst 33342 and doxorubicin binding were
assayed by quenching the tryptophan ﬂuorescence using reconstituted BmrA25 in
50mM Hepes pH 8. Excitation wavelength was 295 nm and emission ﬂuorescence
was recorded between 310 and 380 nm. Measurements were carried out using a
Photon Technology International spectro-ﬂuorimeter with an 814 photomultiplier
detection system using a 75W xenon short arc lamp. All experiments were per-
formed at 25 °C with 0.33 µM BmrA (monomer concentration) in 1 mL cuvette.
Excitation wavelength was 295 nm and emission ﬂuorescence was recorded between
310 and 380 nm. Final quenching spectra were obtained after both corrections from
spectra obtained with empty liposomes in the same buffer and from the inner-ﬁlter
effect by using N-acetyl-tryptophanamide (NATA): three cuvettes were prepared to
which we successively added ligand concentrations: empty liposomes, empty
liposomes+NATA, and proteoliposomes. For each ligand concentration, the ratio
F= (Fc/Fc0)protein/(Fc/Fc0)NATA was calculated, where Fc is the ﬂuorescence
corrected from the buffer containing empty liposomes and Fc0 similarly corrected
in absence of ligand. Quenching data were analyzed according to the equation
F= Fmax− ((Fmax− Fmin)((Et+ L+Kd)− ((Et+ L+ Kd)2–4EtL)0.5))/2Et,
where Et is the enzyme concentration, L the ligand concentration, Fmax is the
ﬂuorescence at the start of the titration, and Fmin the ﬂuorescence at saturating
concentration of ligand.
Limited proteolysis experiments. BmrA E474R and wild-type in lipids (LPR 0.5)
at ~0.8 mgmL−1 were incubated in 50 mM Tris-HCl pH 8, 100 mM NaCl, 5%
glycerol (v/v), and 0.5 µg mL−1 of porcine trypsin (Sigma) with or without 10 mM
ATP, 11 mMMgCl2, and 1 mM vanadate. In order to stop proteolysis, 0.5% (v/v) of
triﬂuoroacetic acid and 2% (m/v) SDS were added. The sample was immediately
frozen in liquid nitrogen.
BmrA homology model. The BmrA homology model was built starting from
the Sav1866 structure (pdb 2hyd2).
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
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